Loading clinical trials...
Loading clinical trials...
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Cedars-Sinai Medical Center, Los Angeles
Los Angeles, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Houston Methodist Hospital
Houston, Texas, United States
St Vincent's Hospital
Sydney, Australia
Toronto Heart Center
Toronto, Canada
St. Paul's Hospital
Vancouver, Canada
Rigshospitalet
Copenhagen, Denmark
CHU Bordeaux
Bourdeaux, France
Lille University Hospital
Lille, France
Civils Hospices of Lyon
Lyon, France
Start Date
November 1, 2020
Primary Completion Date
March 1, 2025
Completion Date
December 31, 2030
Last Updated
May 17, 2022
800
ESTIMATED participants
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
NCT07450911
NCT03142152
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06282042